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On May 7, 2009, a national network was organized in 
the People’s Republic of China for the surveillance, reporting, 
diagnosis, and treatment of influenza A pandemic (H1N1) 
2009 virus infection (pandemic [H1N1] 2009). Persons with 
suspected cases are required to report to the Chinese Cen-
ter for Disease Control and Prevention and the Ministry of 
Health within 24 hours; the patient’s close contacts are then 
traced and placed in quarantine for 7 days. We report 3 con-
firmed early cases of pandemic (H1N1) 2009. Two cases 
were imported from United States; the other was imported 
from Canada. The patients exhibited fever and signs and 
other symptoms that were indistinguishable from those of 
seasonal influenza. Serial virologic monitoring of pharyn-
geal swabs showed that they were negative for pandemic 
(H1N1) 2009 virus by real-time reverse transcription–PCR 
4–6 days after onset of illness. One close contact whose 
sample tested positive for pandemic (H1N1) 2009 virus had 
no symptoms during quarantine. A national network is es-
sential for controlling pandemic (H1N1) 2009.
I
n early April 2009, human infections caused by an influ-
enza virus designated as influenza A pandemic (H1N1) 
2009  virus  (pandemic  [H1N1]  2009)  were  identified  in 
United States (1,2) and Mexico (3) and spread rapidly to 
other regions of the world (4,5). Pandemic (H1N1) 2009 
virus has been reported to be a triple reassortant influenza 
virus (containing genes from human, porcine, and avian 
influenza viruses) that has circulated among swine in the 
United  States  since  1999  (6–8).  Sporadic  human  infec-
tions by influenza virus of swine origin had been described, 
mostly in young persons in contact with pigs (9). The cur-
rent  outbreak  indicates  that  the  new  pandemic  (H1N1) 
2009 virus can be transmitted from human to human. As of 
June 17, 2009, a total of 88 countries officially reported a 
cumulative total of 39,620 laboratory-confirmed pandemic 
(H1N1) 2009 cases; these cases occurred in Mexico (6,241 
cases [including 108 deaths]), the United States (17,855 
[44 deaths]), Canada (4,049 [7 deaths]), Chile (2,335 [2 
deaths]), Argentina (733 [1 death]), the United Kingdom 
(1,461 [1 death]), Costa Rica (149 [1 death]), Australia 
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(2,112), Japan (666), the People’s Republic of China (382), 
Germany (195), France (118), and other countries (10). In 
this report, we describe the clinical and epidemiologic char-
acteristics of 3 early confirmed cases of pandemic (H1N1) 
2009 in China.
Methods
Surveillance, Reporting, and Data Collection
On May  7, 2009,  a  national network for monitor-
ing pandemic (H1N1) 2009 was organized in China. The 
partners included the Ministry of Health (MOH), the Chi-
nese Center for Disease Control and Prevention (Chinese 
CDC), and all community hospitals and teaching hospi-
tals. A guideline for the surveillance, reporting, diagnosis, 
and treatment of pandemic (H1N1) 2009 was published 
on May 9, 2009. Any ill persons with a body tempera-
ture >37.5°C were asked to visit the fever clinics in local   
general hospitals.
A confirmed case of human infection with pandemic 
(H1N1) 2009 virus was defined as laboratory confirmation 
of infection from a human sample at the Chinese CDC or 
the Chinese Academy of Medical Sciences (CAMS) (see 
the Laboratory Confirmation section below). A suspected 
case was defined as 1) an influenza-like illness (ILI; fever 
>37.5°C with at least 1 symptom or sign, including sore 
throat,  cough,  rhinorrhea,  nasal  congestion)  in  a  person 
who has traveled to a country where >1 confirmed pandem-
ic (H1N1) 2009 cases had been found in the past 7 days, 
or 2) clinical symptoms or signs of ILI in a person with an 
epidemiologic link to a patient found to have confirmed or 
suspected pandemic (H1N1) 2009 in the previous 7 days.
Close contacts were defined as persons who had lived 
with a person with probable or confirmed pandemic (H1N1) 
2009 or who had had direct contact with the respiratory se-
cretions or body fluids of such persons. All close contacts 
were quarantined for medical observation for 7 days; dur-
ing this time, pharyngeal swabs were collected for identifi-
cation of pandemic (H1N1) 2009 virus (once if results were 
negative; serial repeat tests if results were positive).
All suspected cases were required to be reported to the 
Chinese CDC and to the MOH within 24 hours of diagno-
sis. Pharyngeal swabs were forwarded to a local branch of 
the Chinese CDC for detection of influenza A pandemic 
(H1N1) 2009 virus by real-time reverse transcription–PCR 
(RT-PCR). All patients with a positive RT-PCR result for 
pandemic (H1N1) 2009 virus were admitted to the local 
infectious disease hospital where the patient was placed in 
isolation. Additional specimens were sent to the State Refer-
ence Influenza Laboratories at the Chinese CDC or CAMS 
for further characterization and nucleic acid sequencing.
A standardized surveillance reporting form was used 
to  collect  clinical,  epidemiologic,  or  demographic  data. 
We included information about the patient’s demographic 
characteristics, underlying medical conditions, status with 
respect  to  seasonal  influenza  vaccination,  exposures  to 
swine and other animals, travel to a country with confirmed 
pandemic (H1N1) 2009 infection, clinical signs and symp-
toms, chest radiograph results, laboratory findings, results 
of diagnostic testing for influenza, antiviral treatment, clin-
ical complications, and clinical outcome.
Laboratory Confirmation
Pharyngeal swabs were collected from all patients and 
their close contacts, which were submitted to local branch of 
the Chinese CDC and reference laboratories in the Chinese 
CDC or CAMS for investigation. We used the protocol of 
the US Centers for Disease Control and Prevention of real-
time RT-PCR for pandemic (H1N1) 2009 as recommended 
by the World Health Organization (11). The PCR products 
were sequenced for further confirmation by standard high-
throughput sequencing system with the use of BigDye Ter-
minator, version 3.1 (Applied Biosystems, Foster City, CA, 
USA) with 1 mm3 of double-stranded template.
Results
The  demographic  and  epidemiologic  characteristics 
of the 3 patients with confirmed pandemic (H1N1) 2009, 
including the estimated disease incubation period and their 
travel histories, are listed in Table 1. Their clinical charac-
teristics are shown in Table 2. All 3 patients were Chinese 
students who had been studying abroad (2 in United States 
and 1 in Canada).
Patient 1 left St. Louis, Missouri, USA, on May 7, 
2009 (US date), and flew to St. Paul, Minnesota, USA, 
where he transferred to a flight to Tokyo, Japan, then to 
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Table 1. Demographic and epidemiologic characteristics of 3 patients infected with influenza A pandemic (H1N1) 2009 virus, People’s
Republic of China, 2009 
Characteristic Patient 1 Patient 2 Patient 3
Age, y 30 19 18
Sex M M F
City of origin St. Louis, MO, USA Winnipeg, Manitoba, Canada New York, NY, USA
Date of illness onset May 9 May 10 May 13
Site of illness onset Airplane Hotel Home
City of illness onset Beijing Beijing Beijing
City of virus isolation Chengdu Jinan BeijingRESEARCH
Beijing, China, arriving on May 8 (Beijing date). The pa-
tient did not experience illness, and fever did not develop 
during the flight from St. Louis to Beijing. At the Beijing 
airport, his temperature was normal. The patient stayed in 
Beijing for 1 night and boarded a flight to Chengdu on May 
9. He did not report feeling ill before the flight. On the flight 
from Beijing to Chengdu, fever developed. Upon landing, 
the patient went to a hospital for medical attention for his 
illness. The case was reported to the Chinese CDC, and 
specimens were collected on May 9. A test result for pan-
demic (H1N1) 2009 virus was positive on May 10 by real-
time RT-PCR. All 144 close contacts (including his father, 
girlfriend, taxi driver, and all passengers on the flight from 
Chendu to Beijing) were quarantined in hotels for medical 
observation for 7 days.
Patient 2 left Winnipeg, Manitoba, Canada, on May 7 
(Canada date) and arrived in Beijing on May 8 (Beijing date). 
He did not feel ill while traveling from Winnipeg to Beijing. 
He stayed for 2 days in Beijing, where a fever developed, but 
he did not seek medical attention. The patient subsequently 
took a train from Beijing to Jinan on May 11 and, on arrival, 
went to the local infectious diseases hospital. There was no 
thermal scanner for fever at the train station in Beijing. The 
case was reported to the Chinese CDC, and specimens were 
collected on May 11. The pandemic (H1N1) 2009 virus test 
result was positive on May 12 by real-time RT-PCR. All 40 
close contacts sitting in the same car of the train were quar-
antined for medical observation for 7 days.
Patient 3 left New York, New York, USA, on May 10 
(US date) and arrived at home in Beijing on May 11 (Bei-
jing date). She was well when traveling from New York 
to Beijing. Her temperature was normal at border health/
temperature monitoring. She stayed home with her mother 
and did not meet other persons and visit other places. A 
fever developed on May 13 (Beijing date), and she sought 
medical attention on the evening of May 14. The case was 
reported to Chinese CDC, and specimens were collected on 
May 15. The test result for pandemic (H1N1) 2009 virus 
was positive on May 15 by real-time RT-PCR. Her mother 
and a taxi driver were the only close contacts.
All 3 patients were positive for pandemic (H1N1) 2009 
virus by real-time RT-PCR, and further confirmed PCR 
products  sequencing  the  partial  hemagglutinin  sequence 
from all 3 patients were 99.5–100% homologous with A/
California/4/2009 but only 79.4%–79.6% homologous with 
seasonal  influenza  virus  (H1N1)  (A/Brisbane/59/2007) 
(Table 3). The dynamic virologic monitoring of pharyngeal 
swab samples from the 3 case-patients showed that real-
time RT-PCR results for influenza A pandemic (H1N1) 
2009 virus were negative on day 5, day 7, and day 6, re-
spectively (Table 3).
Only 1 sample from a total of 186 close contacts tested 
positive for pandemic (H1N1) 2009 virus by real-time RT-
PCR. This sample came from the 48-year-old mother of 
patient 3, who had lived with patient 3 for 2 days before her 
illness and had taken care of her for 2 days after her illness 
began. On the fifth day (May 16) after exposure to patient 
3, the woman’s sample became positive (Table 3). As with 
all the other close contacts, this woman had no fever or ILI 
symptoms.
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Table 2. Clinical characteristics of 3 patients infected with influenza A pandemic (H1N1) 2009 virus, People’s Republic of China, 2009* 
Characteristic Patient 1 Patient 2 Patient 3
Chronic illness No No No
Influenza vaccine in last flu season No No No
Highest temperature, °C 38.8 39 39.4
Sore throat Yes Yes Yes
Cough Yes No Yes
Rhinorrhea Yes No Yes
Nasal congestion Yes No No
Headache Yes Yes Yes
Diarrhea No No No
Other symptoms No Decreased appetite Chest pain
Leukocyte count, per mm
3 7,900 4,900 5,300
Neutrophil count, per mm
3 5,480 2,810 4,000
Lymphocyte count, per mm
3 1,540 1,580 1,000
Platelet count, per mm
3 166,000 208,000 254,000
C-reactive protein, mg/L 39 Not done 0.3
Findings on chest radiograph Normal Normal Normal
Oseltamivir treatment* Yes Yes Yes
Duration of fever, d 2 3 3
Length of stay in hospital, d† 8 8 8
Outcome Recovered Recovered Recovered
*75 mg 2x/d for 5 d. 
†During their stay in hospital, no patient needed oxygen or a ventilator. They were kept in hospitals for isolation and close observation because pandemic 
(H1N1) 2009 was an infectious disease new to physicians in China.  Influenza A Pandemic (H1N1) 2009 Virus Infection, China
Discussion
The 3 cases were mild, and the patients were young, 
which  is  consistent  with  the  profile  of  other  pandemic 
(H1N1)  2009  infections  reported  around  the  world  (6). 
The most frequent signs and symptoms in the patients were   
fever and other manifestations that were nonspecific for 
pandemic (H1N1) 2009 and indistinguishable from those 
of seasonal influenza. None of them had evidence of se-
vere lower respiratory tract illness or unusual symptoms of 
influenza, such as diarrhea. All patients recovered quickly, 
with a median duration of fever of 3 days. All 3 patients had 
complete blood counts performed during the course of their 
disease, but none had leukopenia (leukocyte count <4,000/
mm3), or lymphopenia (total lymphocyte count <800/mm3), 
or thrombocytopenia (total platelet count <100,000/mm3).
The transmissibility of influenza A pandemic (H1N1) 
2009 virus is uncertain. One study assumed that its trans-
missibility (R0) is substantially higher than that of seasonal 
influenza and comparable with the viruses in previous in-
fluenza pandemics (12). Our study demonstrates, on the 
basis of PCR testing, that the average time of pandemic 
(H1N1) 2009 virus shedding is 4–6 days. Positive RT-PCR 
results do not necessarily confirm virus shedding, but the 
PCR-based method is more sensitive than culture methods 
for detecting virus shedding (13). Our study also shows 
that the risk for person-to-person transmission is greatest in 
households. Among 186 close contacts, only the mother of 
patient 3, who lived with her, had a positive result for pan-
demic (H1N1) 2009 virus by real-time RT-PCR, although 
she had no symptoms of influenza. All other close contacts, 
including taxi drivers, passengers in an airplane or the same 
car of a train, were negative for pandemic (H1N1) 2009 
virus at screening, and illness did not develop subsequently 
while they were being observed. Asymptomatic infections 
appear to be possible among household members, as dem-
onstrated by case-patient 3 and her mother.
Our study has several limitations. First, numbers in 
this series were low. Second, the exact date of exposure to 
a known infectious source was difficult to trace. Third, pha-
ryngeal swab samples may have a lower sensitivity (than 
nasopharyngeal),  and  thus  some  false-negative  results 
might have occurred, which could lead to underestimation 
of viral shedding.
A national network for the surveillance and control of 
pandemic (H1N1) 2009 was quickly organized in China, 
and the response was quick and thorough. The Chinese 
government is moving swiftly to contain the new influenza, 
drawing on lessons from the severe acute respiratory syn-
drome and bird influenza outbreaks in recent years. In all 
airports, thermal scanners have been installed, and all as-
ymptomatic contacts of case-patients were quarantined for 
7 days as part of the early response. As the number of im-
ported cases has increased, the quarantine policy is chang-
ing. During the past 4 weeks, only symptomatic travelers at 
ports of entry and passengers sitting within a short distance 
(<2 m) to a person with a suspected or confirmed case were 
quarantined. As local transmission has been documented, 
more efforts have been paid to communities. Since June 
22, hand temperature monitors were used in all schools in 
Beijing. All students with body temperatures >37.2°C were 
asked to stay at home until their temperature returned to 
normal. Further evaluation is needed to continue to clarify 
the nature of pandemic (H1N1) 2009, including its clinical 
features, severity, incubation period, and transmission pat-
terns (14).
Dr Cao is the director of the Department of Infectious Dis-
eases  and  Clinical  Microbiology,  Beijing  Chaoyang  Hospital, 
Capital Medical University, Beijing. His research interests focus 
on the diagnosis and treatment of respiratory tract infections.
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